How to Test Seal Integrity on Sterile Packaging

Sterile medical packaging is the ultimate shield for patient safety and a cornerstone of regulatory compliance. In a field where a malfunction can cost lives, testing must be thorough and documented. Compliance is non-negotiable, and packaging validation must follow a risk-based, science-driven approach as outlined in ISO 11607 and USP <1207>. When a surgeon opens a pouch or a nurse prepares an implant, the seal must hold. There is no second chance.

This blog concentrates on medical device packaging, but similar principles apply to food and pharmaceutical packaging lines, where contamination risks can also lead to serious health hazards and costly recalls.

Key Takeaways for Testing Seal Integrity

What Is Seal Integrity Testing?

Seal integrity testing confirms that packaging seals preserve a sterile barrier during sterilization, storage, and distribution since integrity can weaken over time. It ensures seals are free from leaks, channels, or weak points that could compromise sterility. Unlike a quick visual check, integrity testing uses deterministic methods preferred by regulators for reproducible quantitative results simulating real-world conditions such as sterilization cycles, pressure changes, and distribution stress.

Seal Integrity vs Seal Strength: Understanding the Difference

Seal integrity and seal strength are not the same. Seal integrity means there are no channels or leaks that could compromise the sterile barrier, ensuring protection against microbial ingress. Many sterile barrier systems, such as Tyvek® or medical-grade paper, are intentionally porous to allow sterilant penetration. Seal strength, by contrast, refers to peel force or overall seal robustness. A seal can be strong yet fail to maintain sterile integrity. Both attributes are critical, but integrity is the foundation of patient safety.

Why Seal Integrity Matters for Medical Devices

In the context of medical device testing, even a single compromised seal can increase infection risk, trigger non compliance, and lead to recalls. Microscopic flaws can compromise sterility. Micro-leak detection is essential to prevent contamination and costly recalls. Each package must withstand real-world stress.

Overview of Standards and Regulatory Requirements (ISO 11607, ASTM, FDA)

Global standards and regulatory frameworks for seal integrity and container closure integrity testing (CCIT) in medical packaging include:

• MDR Annex I (General Safety and Performance Requirements)
  • Chapter II – Infection & Microbial Contamination:
    11.4 requires sterile devices to remain sterile until point of use, with packaging integrity clearly evident to the user.
    11.5 mandates validated methods for processing, packaging, and sterilization
  • Chapter III – Information Supplied:
    Sections 23.3 / 23.4 define what must be stated in IFUs regarding sterile packaging (e.g., actions if packaging is damaged).
• EN ISO 11607-1/-2
  The harmonized standard under MDR for sterile barrier systems and sealing process validation. It provides the framework for packaging design, seal integrity testing, and process validation.
• USP <1207>
  Risk-based approaches and deterministic methods for CCIT.
• EU GMP Annex 1
  Guidance for sterile medicinal product manufacturing under EudraLex Volume 4. Primarily relevant for pharma and combination products, with strong emphasis on contamination control and aseptic processing.
• EU GMP Annex 1
  Guidance for sterile medicinal product manufacturing under EudraLex Volume 4. Primarily relevant for pharma and combination products, with strong emphasis on contamination control and aseptic processing.
• FDA Guidance
  Science-based, validated testing expectations for sterile packaging and sealing processes.

Interaction Between MDR, ISO 11607, and EU GMP Annex 1

MDR sets the legal requirements for sterile medical devices, while ISO 11607 provides the technical framework for packaging design, seal integrity testing, and process validation. EN ISO 11607 is harmonized under MDR, so applying it typically demonstrates conformity. EU GMP Annex 1 governs sterile medicinal products but overlaps on contamination control and validated processes.

In practice: MDR defines what must be achieved, ISO 11607 shows how to prove it, and Annex 1 applies to combination products or when supplying components to pharma.

Common Seal Integrity Test Methods

Different methods apply depending on packaging type, material, and risk level. Common approaches include both probabilistic and deterministic techniques. These methods range from basic visual checks to advanced leak testing techniques designed for medical-grade packaging. Below is a list of widely used methods:

Probalilistic, Destructive Seal Integrity Test Methods

Deterministic, Non-Destructive Seal Integrity Test Methods

Not All Methods Are Adequate for Sterile Packaging

While many of these methods are useful for general seal integrity checks, sterile packaging requires a higher level of assurance. Regulatory standards such as USP <1207> and ISO 11607 emphasize deterministic methods because they provide accurate, reproducible, and science-based results. Probabilistic methods can be acceptable for certain risk levels and use cases, but they are more subjective / less sensitive and are often complemented with deterministic methods where quantitative leak-rate assurance is required.

Deterministic Methods Suitable for Seal Integrity Testing or CCIT

The following table lists deterministic methods recommended for CCIT. These methods are considered best practices for sterile packaging.

Integrating Seal Integrity Testing into Medical Device Packaging Validation

It is important to account for seal integrity testing in the planning stages of a new product launch. It should be designed into the initial validation plan to maintain sterility and meet strict regulatory requirements. Waiting until the project is already underway or treating seal integrity as an afterthought can produce issues in manufacturing that were initially overlooked. Manual and fragmented processes create audit risks. Automation and organized documentation for traceability eliminate these hurdles.

Seal integrity tests confirm that seals prevent leaks and contamination, while validation ensures packaging withstands sterilization, storage, and distribution. Compliance with ISO 11607 involves verifying sealing parameters such as temperature, pressure, and dwell time. Accelerated aging tests (ASTM F1980) simulate shelf life, and distribution simulations (ASTM D4169) replicate transport stresses. Seal integrity testing must integrate with IQ, OQ, and PQ validation phases to ensure compliance and provide documented proof for audits.

Automating Seal Integrity Tests for Repeatability and Traceability

Automation in medical device or packaging production is vital because it ensures repeatability, traceability, and audit-ready compliance documentation. By combining automated vision inspection systems with expertise in IQ, OQ, and PQ protocols, medtech teams simplify validation, reduce re-validation time, and accelerate compliance without compromising safety.

Automated test equipment delivers consistent test cycles and clear pass/fail criteria, while enabling micro-leak detection through precise pressure control. They integrate seamlessly with manufacturing execution systems (MES) and laboratory information management systems (LIMS), providing digital records and audit-ready data to strengthen compliance. This level of automation reduces human error, improves reliability, and guarantees confidence in every test.

Common Issues and How to Prevent Seal Failure

Below is a table summarizing frequent challenges in seal integrity testing and practical proactive steps to prevent them:

Common Issue	Preventive Measure
Contamination on sealing surfaces	Clean and inspect surfaces before sealing
Material variation	Use validated materials and monitor supplier quality
Weak seals or channels	Optimize sealing parameters and perform routine checks
Micro-leaks	Implement deterministic testing and automated detection
Incorrect sealing temperature or pressure	Calibrate equipment regularly and maintain process control
Die misalignment	Schedule preventive maintenance and alignment verification

Choosing the Right Seal Integrity Tester

Choosing the right seal integrity tester requires evaluating packaging types such as pouches, trays, and blisters, porous versus non-porous materials, and sensitivity for micro-leak detection. Sensitivity for micro-leak detection is critical for high-risk applications, so manufacturers should evaluate test methods such as bubble emission, dye penetration, pressure decay, and vacuum decay. The system must support preferred methods while offering the right automation level, scalability for production volumes, and equipment accuracy to meet regulatory standards. A well-chosen tester ensures compliance and long-term efficiency by combining precise detection with robust automation. Selecting equipment that supports CCIT and automated medical packaging inspection ensures compliance and scalability for high-risk applications.

Work with Experts in Medical Packaging Test Automation

Seal integrity and CCIT are complex, but they do not have to be overwhelming. Working with experienced specialists helps ensure that your testing strategy meets regulatory requirements while optimizing efficiency. Experts can guide you in selecting the right methods, integrating automation, and achieving reliable, repeatable results that protect product quality and patient safety. They can also help define and execute IQ, OQ, and PQ protocols, ensuring your packaging validation meets FDA and MDR requirements with complete documentation.

The Future of Seal Integrity Testing in Medical Packaging

Automated seal inspection is reshaping the industry with precision, speed, and traceability. The future lies in leveraging advanced technologies alongside robust validation processes to guarantee the highest level of quality and compliance.

Ready to optimize seal integrity testing and guarantee packaging compliance? Contact Averna today to discover automated solutions that deliver precision, traceability, and regulatory confidence!

Reviewed and edited by

Arno Veldhuis - Customer Solutions Architect

Averna veteran, Arno Veldhuis is a leading expert in vision and optical technology, bringing diverse experience to the test and measurement world with a background in mechanical engineering. He currently acts as a customer solutions architect, bridging technical specifications to meet business requirements by designing innovative and cost-effective systems. With a focus on the medical industry, Arno has aligned Averna’s global practices to meet the stringent requirements of the field, allowing Averna customers to meet compliance faster and accelerate production.

LinkedIn

You may also be interested in…

Ready to complement CCIT with automation best practices? Discover how automated methods improve sensitivity and deliver clean, verifiable records for regulators!

Get in touch with our experts or navigate through our resource center.